Last reviewed · How we verify
NCT04702126
Smoking Effect on Lumbar Intervertebral Disc Degeneration
trial in Intervertebral Disc Degeneration in 360 participants. Completed in 1 February 2020.
1 February 2020
Quick facts
| Lead sponsor | Fatih Sultan Mehmet Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 360 |
| Start date | 1 September 2019 |
| Primary completion | 1 February 2020 |
| Estimated completion | 1 February 2020 |
| Sites | 2 locations across Turkey (Türkiye) |
Conditions studied
- Intervertebral Disc Degeneration — all drugs for Intervertebral Disc Degeneration →
Sponsor
Fatih Sultan Mehmet Training and Research Hospital
Who can join
Adults 20 to 70, any sex, with Intervertebral Disc Degeneration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Besides normal aging, genetic and environmental factors are important potential determinants of lumbar disc degeneration. Smoking causes serious health problems, particularly lung and other cancers, heart disease and respiratory diseases, and is among the most common causes of death worldwide. Besides these commonly known diseases related to smoking numerous studies have shown that smoking has detrimental effects on the musculoskeletal system and worsens the prognosis and treatment of leukomotor diseases. In the literature there are studies examining the effect of smoking status on disc degeneration. The aim of the study was to investigate the effect of current, former and passive smoking status on degeneration of lumbar intervertebral discs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04702126
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intervertebral Disc Degeneration
Currently open trials in the same condition.
- NCT07168603 — EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease · Phase 1, PHASE2 · recruiting
- NCT06342765 — Safety and Performance of the SpineVision Posterior Fixation Systems in Thoracolumbar Spinal Treatment · recruiting
- NCT05299762 — A Post Market Surveillance on INFUSE Bone Graft · recruiting
- NCT05648474 — Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure · recruiting
- NCT05997121 — Safety and Performance of the Hexanium TLIF System in the Treatment of Degenerative Disc Disease · recruiting
Other Fatih Sultan Mehmet Training and Research Hospital trials
Trials by the same sponsor.
- NCT07589582 — Active Noise-Cancelling Headphones Reduce Operative Time and Improve Procedural Consistency in ACL Reconstruction l · NA · active not recruiting
- NCT07523828 — Laryngeal Edema Assessment by Cuff Leak Test and Ultrasound in ICU Patients and Its Relationship With Weaning Success · not yet recruiting
- NCT07487038 — The Efficacy and Safety of a Single-Dose Hyaluronic Acid Injection in the Treatment of Knee Osteoarthritis · not yet recruiting
- NCT07485465 — Lymphoedema Diagnosis and Treatment · not yet recruiting
- NCT07451925 — Prediction of Postoperative Pain Using Venous Cannulation Pain and Preoperative Anxiety Scores · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04702126 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fatih Sultan Mehmet Training and Research Hospital
- Last refreshed: 8 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04702126.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing